Upfront Diagnostics

📍 Cambridge, United Kingdom🗓 Founded 2017👥 9 employees💰 Last funded Nov 2025
Biotechnology🌐 upfrontdiagnostics.com
Website LinkedIn
Medtech company commercialising the 1st Rapid Blood Test for Strokes, the LVOne. Founded in Cambridge, UK, in 2017, our mission is to revolutionise emergency stroke care. We are dedicated to discovering and applying novel biomarkers that help professionals to deliver better, more cost-effective care. We have established strong traction and are manufacturing-ready for global commercialisation: ➠ LVOnes high performance is validated in multiple clinical studies and is active in trials worldwide. ➠ ISO 13485 certified company. ➠ We have established Manufacturing Readiness, positioning us for scalable market entry. Join us in the stroke diagnostics revolution.
2
Total investors
1
Early stage
0
Mid stage
1
Late stage
2017
Founded

Investors

2 investors
All
Early stage
Mid stage
Late stage
Investor geography2 countries
United Kingdom
1
Germany
1
Frequently asked questions
Who invested in Upfront Diagnostics?
Upfront Diagnostics has 2 investors on record on gritt.io, including 1 early-stage backers and 1 late-stage investors.
When did Upfront Diagnostics last raise funding?
The most recent investment in Upfront Diagnostics recorded on gritt.io was in November 2025.
When was Upfront Diagnostics founded?
Upfront Diagnostics was founded in 2017.
What industry is Upfront Diagnostics in?
Upfront Diagnostics operates in Biotechnology. Find similar Biotechnology investors on gritt.io.
Where is Upfront Diagnostics based?
Upfront Diagnostics is headquartered in Cambridge, United Kingdom.